Viewing nowCombinationRichstar Tablet 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Punglim Pharmaceutical Co., Ltd.

MFDS item code 201700544 · Approved 2017.01.31 · Insurance code 649001660
Treatment of essential hypertension not controlled with monotherapy
This medication can be used effectively to control blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with telmisartan or amlodipine alone. This helps reduce the risk of cardiovascular complications associated with high blood pressure and improves the patient's health status. This medication contributes to an overall improvement in the patient's quality of life by stabilizing blood pressure.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase it gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Pediatric patients aged 18 years or younger: This medicine is not recommended because its safety and efficacy have not been established.
This medication should not be used during pregnancy, especially during the second and third trimesters, as it can pose a serious risk to the fetus. It should not be administered to individuals with allergies to this medication’s active ingredients or similar drugs, as well as to women who are pregnant or breastfeeding, and to patients with certain liver or heart diseases. Patients with liver or gastrointestinal diseases, reduced kidney function, elderly patients, and those with specific heart valve diseases should use this medication with caution. Side effects such as dizziness or edema may commonly occur during treatment, and serious side effects may rarely develop; therefore, any unusual symptoms should be promptly discussed with healthcare professionals. As this medication can cause a sudden drop in blood pressure, if hypotension is suspected, the patient should be laid down and receive intravenous therapy if necessary, and the dosage should be adjusted according to medical guidance when initiating treatment. This medication can increase potassium levels; hence, blood potassium levels should be regularly monitored when taken with potassium supplements or medications containing potassium. Patients with diminished kidney function should have their kidney function and electrolyte levels routinely checked before and after taking this medication. This medication can interact with other antihypertensive drugs and specific medications, so it is essential to inform healthcare professionals of any other medications being taken. Dizziness or drowsiness may occur when driving or operating dangerous machinery, so caution should be exercised. In cases of overdose, severe hypotension or heart-related issues may occur; therefore, adherence to the prescribed dosage is crucial, and immediate contact with healthcare institutions is necessary in the case of an overdose. This medication is not recommended for children as its safety and efficacy have not been sufficiently established in this population. When storing, keep it out of reach of children, take it immediately after opening, and do not transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light; therefore, it should be stored in a container that does not allow light to enter. Additionally, it is crucial to maintain a room temperature between 1 and 30 degrees Celsius when storing the medication to ensure its effectiveness is safely preserved.
It is a biconvex oval-shaped double tablet that is white and light gray.
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Punglim Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.